ETS1苏氨酸38位点磷酸化与弥漫大B细胞淋巴瘤起源细胞相关并维持肿瘤细胞生长
在25%的弥漫大B细胞淋巴瘤(DLBCL)中ETS1转录因子上调。本研究在DLBCL细胞模型和临床标本中探讨ETS1苏氨酸38位点磷酸化(ETS1激活标志)的作用。p-ETS1见于活化B细胞样(ABC)DLBCL而不见于生发中心B细胞样(GCB)DLBCL细胞系,在ABC型诊断活检中较GCB型更常见;MEK抑制降低基线及IgM刺激诱导的p-ETS1水平;基因抑制该位点磷酸化影响DLBCL细胞系生长及BCR介导的转录组程序。
要点
- p-ETS1在ABC型DLBCL细胞系中检出,GCB型细胞系中未检出
- p-ETS1在ABC型诊断活检中较GCB型更常见
- MEK抑制降低基线及IgM刺激诱导的p-ETS1水平
核心结论
- ETS1苏氨酸38位点磷酸化对DLBCL细胞生长重要,其药理抑制可能使淋巴瘤患者获益。
研究设计与样本
- 研究在DLBCL细胞模型和临床标本中探讨ETS1苏氨酸38位点磷酸化的作用。
主要发现
- p-ETS1在ABC型DLBCL细胞系中检出,在GCB型DLBCL细胞系中未检出。
- p-ETS1在ABC型较GCB型DLBCL诊断活检中更常见。
- MEK抑制降低基线及IgM刺激诱导的p-ETS1水平。
- 基因抑制ETS1苏氨酸38位点磷酸化影响DLBCL细胞系生长及BCR介导的转录组程序。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The transcriptional factor ETS1 is upregulated in 25% of diffuse large B cell lymphoma (DLBCL). Here, we studied the role of ETS1 phosphorylation at threonine 38, a marker for ETS1 activation, in DLBCL cellular models and clinical specimens. p-ETS1 was detected in activated B cell-like DLBCL (ABC), not in germinal centre B-cell-like DLBCL (GCB) cell lines and, accordingly, it was more common in ABC than GCB DLBCL diagnostic biopsies. MEK inhibition decreased both baseline and IgM stimulation-induced p-ETS1 levels. Genetic inhibition of phosphorylation of ETS1 at threonine 38 affected the growth and the BCR-mediated transcriptome program in DLBCL cell lines. Our data demonstrate that ETS1 phosphorylation at threonine 38 is important for the growth of DLBCL cells and its pharmacological inhibition could benefit lymphoma patients.
引用
- Chung EYL, Sartori G, Ponzoni M, et al. ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. Br J Haematol. 2023. PMID: 37584198. doi:10.1111/bjh.19018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。